Topic Listing for Retractable Technologies

Accounting Estimates Accounting Matters
Accounting Pronouncements Accounting Treatment
Accounts Receivable Aggregate Option Sar Exercises Last Fy-end Values
Allocation Between Long-term Current Cash Non-cash Compensation Amended Name
Amendment Amendment Registered Agent Office
Amendment Series Certificate Designation Amendments Articles Incorporation Bylaws Change
Amendments Without Shareholder Vote Amounts Realized Past Compensation Affect Future
Amounts Realized Past Compensation Affect Other Elements Annual Report Form 10-k
Annual Report Form 10-k Quarterly 10-q Annual Report Form 10-ksb
Antitrust Violations Appendix
Applicable Only Corporate Issuers Approval 2008 Stock Option Plan
Approval Amended Restated Bylaws Approval Option Exchange Plan
Approval Stock Option Grant Thomas Shaw Attached Maintenance Fees 011 Patent Been Timely Paid
Audit Committee Audit Committee Financial Expert
Audit Committee Meetings Audit Committee Members
Audit Committee Report Audit Fees
Audit Practices Financial Reporting Matters Audit-related Fees
Authorization Withholding Selection Availability Accountants Meeting
Awards Background Class Director Nominees
Backlog Orders Base Salary
Basis Basis Presentation
Basis Selecting Events Payment Triggers Employment Agreement Thomas Bds Inferior Alleged Safety Syringes Render Competitively Vulnerable
Before Vote Benchmarking Compensation Program
Beneficial Ownership Reporting Compliance Board Directors Recommends Vote Nominees
Board Directors Recommends Vote Nominees Election Class Please Business
Capital Resources Cash Bonuses
Cash Equivalents Cash Requirements
Ceasing Delivery Duplicate Documents Shareholders Certain Relationships Related Transactions
Certain Relationships Related Transactions Director Independence Certification Principal Executive Officer
Certification Principal Financial Officer Change Registered Agent Office
Choose Pay Each Element Compensation Program Class
Class Directors Please Sign Date Return Promptly Enclosed Commercial Advertising Promotion Describe Nature Characteristics Qualities Safety-lok
Commitments Contingencies Common Stock
Communications Board Directors Comparison
Comparison 2005 2004 Comparison 2006 2005
Comparison 2007 2006 Comparison 2009 2008
Comparison Cumulative Total Return Compensation Benefits Committee
Compensation Chief Executive Officer Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Directors
Compensation Pursuant Employment Agreement Compete Monopolistic Marketplace
Competitive Conditions Complaint
Components Executive Compensation Components Executive Officer Compensation
Composition Concentration Certain Risks
Concentration Risks Concentrations Credit Risk
Confidentiality Consent Independent Registered Public Accounting Firm
Consideration Contractual Obligations Commercial Commitments
Controlled Shareholders Controls Procedures
Corporate Governance Count False Advertising Violation Lanham Act
Count Infringement Patent 5578011 Count Infringement Patent 5632733
Count Infringement Patent 6090077 Count Texas Antitrust Act
Count Unfair Competition Count Violations Sherman Clayton Acts
Current Investigations Result Beneficial Legislation Increasing Access Hospital Current Report
Current Report Pursuant Securities Exchange Act 1934 Current Status Series Class Stock
Defaults Senior Securities Definitions
Delivery Duplicate Documents Shareholders Delivery Single Set Documents Household
Departure Directors Certain Officers Election Appointment Compensatory Departure Directors Principal Officers Election Appointment
Dependence Major Customers Describe Nature Characteristics Qualities Eclipse Syringe Violation Lanham
Determinations Awards Granted Determine Amount Formula Payment Light Objectives
Development Deviations
Director Compensation Table 2007 Director Compensation Table 2008
Director Nomination Policies Director Nominations Considered Board 2006
Director Nominations Considered Board 2007 Director Nominations Considered Board 2008
Director Nominations Considered Board 2009 Director Nominations Considered Board 2010
Directors Executive Officers Significant Employees Directorships Other Public Companies
Discussion Balance Sheet Statement Cash Flow Disposable Syringe Was Introduced 1960s Allowed Continue Monopolistic
Distributor Contact Australia Earnings Per Share
Effect Extraordinary Corporate Transactions Options Effect Stockholders
Effectiveness Filing Effects Rights Current Preferred Shareholders
Election Class Directors Election Class Directors Approval Stock Option Grant Thomas
Election Participate Voluntary Eligibility Participants
Employees Employment Agreement
Entry Material Definitive Agreement Environmental Compliance
Exact Name Registrant Specified Charter Exchange Ratio
Execution Executive Committee
Executive Compensation Executive Compensation Policy
Executives Exercise Price New Options
Exhibits Explanatory
External Sources Liquidity Face Inherent Product Liability Risks
Factors Consider Determining Change Compensation Materially False Advertising
Family Relationships Federal Income Tax Consequences
Financial Instruments Financial Statements Exhibits
Fluctuations Supplies Inventory Temporarily Increase Costs Form 10-k
Form 10-q Form 401
Form Proxy Card Former Name Address Changed Since Last Report
Forward-looking Statement Warning General
General Benefits General Description
General Powers Generally Been Unable Gain Sufficient Market Access Achieve
Governance Policies Compliance Government Funding Research Right License
Govt Awards Retractable Technologies Safety Syringe Contract Bush Held 2005
Held 2006 Held 2007
Held 2008 Held 2009
Hierarchy Generally Accepted Accounting Principles Replacement Fasb Statement Historical Sources Liquidity
Immediate Release Impact Accounting Tax Treatments Types Compensation
Implementing Option Exchange Plan Important Notice Regarding Availability Proxy Materials Annual Meeting
Important Notice Regarding Availability Proxy Materials Shareholder Meeting Important Notice Regarding Availability Proxy Materials Special Meeting
Improvements Incentive Stock Options
Income Tax Income Taxes
Incorporation Documents Reference Incorporation Reference Other Information Proxy Statement
Indemnification Independent Directors
Index Financial Statements Individual Grants
Injunctive Relief Instructions Withhold Authority Vote Individual Nominee Except Fill
Intangible Assets Intellectual Property
Intermediate Connector Piece Allows Only Bd-manufactured Syringe Screwed Internal Sources Liquidity
Introduction Inventories
Investor Contact Involvement Certain Legal Proceedings
Iso Requirements Isos Generally
Jurisdiction Venue Labeling
Lack Future Financial Resources Capture Increased Market Share Legal Proceedings
License Agreement License Grant
Licensing Agreement Limitation Assistance Competitors
Limitation Powers Duties Responsibilities Limited Access Capital Markets
Limited Discretionary Authority Vote Proxies Liquidity
Liquidity Future Capital Requirements Litigation Proceeds
Litigation Settlements Lobo Lane Little Elm Texas 75068-0009
Long-lived Assets Long-term Incentive Compensation
Long-term Incentive Stock Options Long-term Incentives Stock Options
Managements Discussion Analysis Financial Condition Results Operations Margins Market Access
Market Registrants Common Equity Related Stockholder Matters Issuer Marketed Continues Market Infringing Integra Syringes Within Texas
Marketing Fees Marketing Fees Payable
Marshall Division Material Changes Financial Condition Results Operations
Material Changes Outside Ordinary Course Business Contractual Obligations Material Commitments Expenditures
Media Contact Meetings
Methods Marketing Distribution Name
Name Person Filing Proxy Statement Other Registrant Name Registrant Specified Charter
Narrative Explanation 2006 Director Compensation Table Supplementary Options Narrative Explanation Director Compensation Table 2007
Narrative Explanation Director Compensation Table 2008 Nature Action
New Licensing Agreement New Plan Benefits
Nominating Committee Nominating Committee Policies
Nominees Non-qualified Stock Option
Non-qualified Stock Options Notes Condensed Financial Statements
Notes Financial Statements Nqso Requirements
Nqsos Generally Objectives Compensation Plan
Objectives Compensation Program Obtain Information Vote Person
Other Altered Added Deleted Provisions Other Assets
Other Events Other Information
Other Matters Other Terms Conditions New Options
Outstanding Equity Awards Year-end Outstanding Options Eligible Option Exchange Plan
Outstanding Voting Securities Rights Oversight Relationship Independent Auditors
Overview Part
Part Ii-other Information Parties
Patent Infringement Patent Protection Aging
Patents Licenses Proprietary Rights Periodic Cash Bonuses
Persons Subject Laws Outside United States Plan
Please Choose Please Detach Along Perforated Line Mail Envelope Provided
Policy Regarding Attendance Annual Meetings Policy Regarding Hedging Stock Ownership
Portions Markets Safety Needle Devices Because Such Practices Potential Modifications Terms Comply Governmental Requirements
Potential Payments Termination Change Control Power Attorney
Powers Duties Responsibilities Prayer Relief
Pre-approval Policies Procedures Preferred Stock
Principal Accounting Fees Services Principal Markets
Principal Products Principal Suppliers Sources Raw Materials
Proceedings Preceding Properties
Property Plant Equipment Proposal Approval Amended Restated Bylaws
Proxy Solicited Behalf Board Directors Proxy Statement
Purchases Some Circumstances Becoming Obligated Repay Past Rebates Purpose
Purposes Committee Pursuant Securities Exchange Act 1934
Quality Quantitative Qualitative Disclosures Market Risk
Quarterly Report Pursuant Securities Exchange Act 1934 Queensland Australia Health System Awards Retractable Technologies Safety
Reason Amendment Reasons Option Exchange Plan
Recent Pronouncements Recitations
Reclassifications Record Stock Transfer
Registered Agent Change Registered Office Change
Regulatory Status Effect Regulation Reimbursed Discounts
Related Party Transactions Report Compensation Benefits Committee Executive
Report Independent Registered Public Accounting Firm Required Approvals
Research Development Result Statutes Growing Awareness Needlestick Problem Healthcare Industry
Results Operations Retractable Technologies Inc
Retractable Technologies Inc Announces Record 2006 Revenues 253 Retractable Technologies Inc Ndex Financial Statements
Retractable Technologies Inc Reports 2007 Sales 191 Retractable Technologies Inc Reports 2007 Sales 263 New
Retractable Technologies Inc Reports 2008 Sales Retractable Technologies Inc Reports 301 Percent Increase Sales
Retractable Technologies Inc Reports Half 2007 Sales 110 Retractable Technologies Inc Reports Half 2008 Sales 118
Retractable Technologies Inc Reports Revenues Unit Sales Increase Retractables Patented Safety Syringe
Revenue Recognition Risk Factors
Role Executive Officers Determining Compensation Role Executives Directors Determining Compensation
Ross Avenue Suite 2600 Dallas Usa 75201 Sale Equity Securities Proceeds
Seasonal Effect Business Seasonality
Securities Exchange Act 1934 Securities Registered Pursuant Act
Security Ownership Certain Beneficial Owners Security Ownership Management
Security Ownership Management Directors Security Ownership Rules
Series Class Series Class Convertible Preferred Stock
Share-based Compensation Shareholder Meeting Held 2009
Shareholder Proposals Presentation 2006 Annual Meeting Shareholder Proposals Presentation 2007 Annual Meeting
Shareholder Proposals Presentation 2008 Annual Meeting Shareholder Proposals Presentation 2009 Annual Meeting
Shareholder Proposals Presentation 2010 Annual Meeting Shipping Handling Costs
Signatures Significant Employees
Statement Approval Statement Purpose
Status New Products Stock Options
Stock Performance Graph Stock-based Compensation
Stockholder List Submission Matters Vote Security Holders
Subsequent Events Summary Compensation Table
Summary Each Element Compensation Syringes Needle Markets F876-54 2-29 3-14 Frost Sullivan
Table Contents Tax Fees
Term New Options Term Termination
Thomas Shaw Trademarks
Transferability Options Transition Report Pursuant Exchange Act 1934
Unregistered Sales Equity Securities Proceeds Vesting New Options
Vote Vote Shares Direct
Vulnerable New Technologies Warranties
What Compensation Program Designed Award What Specific Corporate Performance Taken Account Making Compensation
What Specific Corporate Performance Taken Account Setting Compensation Willful Infringement
Working Capital Practices Working Capital Restrictions Limitations Payment Dividends
Wwwproxyvotecom Xvi Notices
Xvii Miscellaneous 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki